16 results
425
CELU
Celularity Inc - Ordinary Shares
15 Jun 21
Business combination disclosure
12:00am
of the intellectual property portfolio that was built prior to merging into Celgene and during our tenure there. And since our spin-off, we have built upon a very … for the current Bristol Myers programs in CAR-T technology.
During our tenure at Celgene, we built a highly proprietary placental cell platform, as well as very
8-K
EX-3.2
CELU
Celularity Inc - Ordinary Shares
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
has delegated such responsibility.
Section 29. Tenure and Duties of Officers.
(a) General. All officers shall hold office at the pleasure
424B3
un1j1w6 ga1tx
3 May 22
Prospectus supplement
4:06pm
POS AM
m0dn6n
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
gsxyfbd6lgldfwj5
12 Aug 21
Prospectus supplement
4:21pm
424B3
w5p9no8cee qkyvg
1 Jun 22
Prospectus supplement
4:06pm
425
EX-2.1
kfdaa1kouy
8 Jan 21
Business combination disclosure
7:02am
8-K
EX-2.1
6br6 x972jdoi
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
- Prev
- 1
- Next